Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Social Justice | 1 | 2021 | 456 | 0.560 |
Why?
|
| Specialties, Surgical | 1 | 2021 | 391 | 0.540 |
Why?
|
| Bacterial Typing Techniques | 1 | 2016 | 256 | 0.530 |
Why?
|
| Human Rights | 1 | 2017 | 307 | 0.480 |
Why?
|
| Sputum | 1 | 2016 | 476 | 0.470 |
Why?
|
| Physician's Role | 1 | 2021 | 943 | 0.470 |
Why?
|
| Anesthesiology | 1 | 2021 | 1060 | 0.380 |
Why?
|
| International Cooperation | 1 | 2017 | 1420 | 0.370 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2016 | 810 | 0.350 |
Why?
|
| Health Status Disparities | 1 | 2021 | 1797 | 0.340 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 2291 | 0.330 |
Why?
|
| Malawi | 2 | 2018 | 282 | 0.270 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3158 | 0.260 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2016 | 1832 | 0.260 |
Why?
|
| Patient Readmission | 1 | 2018 | 3114 | 0.230 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 5137 | 0.180 |
Why?
|
| Patient Advocacy | 1 | 2021 | 353 | 0.160 |
Why?
|
| Moral Obligations | 1 | 2017 | 96 | 0.140 |
Why?
|
| United Nations | 1 | 2017 | 165 | 0.140 |
Why?
|
| Hospital Administration | 1 | 2020 | 353 | 0.140 |
Why?
|
| Gallbladder Diseases | 1 | 2016 | 125 | 0.130 |
Why?
|
| HIV Infections | 2 | 2018 | 16718 | 0.120 |
Why?
|
| Rifampin | 1 | 2016 | 315 | 0.120 |
Why?
|
| Cholecystectomy | 1 | 2016 | 395 | 0.120 |
Why?
|
| Operating Rooms | 1 | 2020 | 817 | 0.110 |
Why?
|
| Sex Distribution | 1 | 2018 | 2297 | 0.110 |
Why?
|
| Cough | 1 | 2016 | 555 | 0.110 |
Why?
|
| Age Distribution | 1 | 2018 | 2902 | 0.100 |
Why?
|
| Microscopy | 1 | 2016 | 903 | 0.090 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2016 | 1035 | 0.080 |
Why?
|
| Health Policy | 1 | 2021 | 2661 | 0.080 |
Why?
|
| Endothelin-1 | 1 | 2010 | 314 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2020 | 3679 | 0.070 |
Why?
|
| Inpatients | 1 | 2018 | 2518 | 0.070 |
Why?
|
| Anesthesia | 1 | 2017 | 1561 | 0.070 |
Why?
|
| Emergency Medical Services | 1 | 2017 | 1917 | 0.060 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 1876 | 0.060 |
Why?
|
| Counseling | 1 | 2013 | 1523 | 0.060 |
Why?
|
| Hospitals | 1 | 2018 | 3952 | 0.060 |
Why?
|
| Quality of Health Care | 1 | 2018 | 4371 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14722 | 0.050 |
Why?
|
| Young Adult | 2 | 2018 | 56430 | 0.050 |
Why?
|
| Materials Management, Hospital | 1 | 2020 | 9 | 0.050 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2020 | 57 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.040 |
Why?
|
| Facility Design and Construction | 1 | 2020 | 87 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 85781 | 0.040 |
Why?
|
| Hospitalization | 1 | 2018 | 10262 | 0.040 |
Why?
|
| Time Factors | 2 | 2017 | 40075 | 0.040 |
Why?
|
| New York City | 1 | 2020 | 710 | 0.040 |
Why?
|
| Humans | 7 | 2021 | 744343 | 0.030 |
Why?
|
| Adult | 4 | 2018 | 214055 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 13881 | 0.030 |
Why?
|
| Telemedicine | 1 | 2013 | 2872 | 0.030 |
Why?
|
| Macrophages | 1 | 2010 | 5655 | 0.030 |
Why?
|
| Middle Aged | 3 | 2018 | 213383 | 0.030 |
Why?
|
| Alaska | 1 | 2013 | 68 | 0.030 |
Why?
|
| United States | 1 | 2021 | 69872 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2018 | 77449 | 0.030 |
Why?
|
| Female | 4 | 2018 | 380194 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 72290 | 0.020 |
Why?
|
| Male | 3 | 2018 | 350118 | 0.020 |
Why?
|
| Receptor, Endothelin A | 1 | 2010 | 58 | 0.020 |
Why?
|
| Receptor, Endothelin B | 1 | 2010 | 41 | 0.020 |
Why?
|
| Aged | 2 | 2018 | 163280 | 0.020 |
Why?
|
| Metalloendopeptidases | 1 | 2010 | 396 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2010 | 311 | 0.020 |
Why?
|
| Critical Care | 1 | 2020 | 2647 | 0.020 |
Why?
|
| Program Development | 1 | 2013 | 1316 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2016 | 6459 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 2892 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 20822 | 0.020 |
Why?
|
| Dogs | 1 | 2010 | 3912 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2013 | 2488 | 0.010 |
Why?
|
| Patient Selection | 1 | 2016 | 4215 | 0.010 |
Why?
|
| Length of Stay | 1 | 2016 | 6309 | 0.010 |
Why?
|
| Rural Population | 1 | 2013 | 2210 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 2216 | 0.010 |
Why?
|
| Kinetics | 1 | 2010 | 6473 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2010 | 1451 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 3396 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2013 | 8324 | 0.010 |
Why?
|
| Base Sequence | 1 | 2010 | 12797 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2010 | 4217 | 0.010 |
Why?
|
| Cell Line | 1 | 2010 | 15997 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 13033 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 63114 | 0.010 |
Why?
|
| Animals | 1 | 2010 | 168757 | 0.000 |
Why?
|
Concepts
(90)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_